Keywords: |
adolescent; adult; cancer chemotherapy; aged; middle aged; hydroxyurea; prednisone; review; doxorubicin; cancer combination chemotherapy; combined modality therapy; cytarabine; methotrexate; phenotype; heredity; neoplasm recurrence, local; antineoplastic combined chemotherapy protocols; cytogenetics; cyclophosphamide; dexamethasone; vincristine; age factors; carmustine; acute lymphoblastic leukemia; time factors; rna; daunorubicin; dactinomycin; asparaginase; sepsis; pregnancy; leukocyte count; sex factors; bone marrow transplantation; adverse drug reaction; therapy; tioguanine; clinical trials; acute disease; mercaptopurine; cytostatic agent; bone marrow aplasia; leukemia, lymphocytic; 4 hydroperoxycyclophosphamide; humans; prognosis; human; male; female; blood and hemopoietic system
|